Simplify Formulation With PAT

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-15-2015
Volume 2015 eBook
Issue 1

PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames.

 

PAT has aided formulation, both pre-and post-filing, by reducing costs and time frames. Contrary to popular beliefs, it doesn’t require big investments.

Download

Pharmaceutical Technology’s 2015 Solid Dosage and Excipients eBook

.

 

 

Articles in this issue
PT0315supp_Tableting_page-1.jpg
Advances in Tableting
PT0315supp_Palatability_page.jpg
Assessing and Improving the Palatability of Pharmaceuticals
PT0315supp_malvern_page.jpg
Analytical Techniques for Oral Solid Dosage Formulation
PT0315_supp_PAT_page.jpg
Simplify Formulation With PAT
PT0315supp_lipids_page.jpg
Boosting Solubility in Lipid-Based Formulations
PT0315supp_products_page.jpg
Innovations in Solid Dosage Equipment
PT0315supp_Dow_page.jpg
Using Polymers for More Efficient Hot-Melt Extrusion and Spray Drying
Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Gerresheimer and Bormioli Pharma to Showcase Containment Solutions at Pharmapack

Susan Haigney
January 20th 2025
Article

The two companies will be exhibiting together after Gerresheimer’s December 2024 acquisition of Bormioli.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Feliza Mirasol
January 15th 2025
Article

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

With New Funding, Orbis Medicines to Develop Oral Macrocycles as Alternative to Biologic Drugs

Feliza Mirasol
January 7th 2025
Article

With the new $94 million (€90 million) funding, the company will develop its pipeline of oral macrocycle drugs, nCycles, against validated biologic targets.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Takeda Receives Japanese Regulatory Approval for HYQVIA Subcutaneous Injection for Treating Agammaglobulinemia or Hypogammaglobulinemia

Feliza Mirasol
January 4th 2025
Article

With this approval, HYQVIA [Immune Globulin Infusion 10% (human) with Recombinant Human Hyaluronidase] becomes the first and only facilitated subcutaneous immunoglobulin available in Japan to treat these disorders.